NGM Biopharmaceuticals: Q4 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — NGM Biopharmaceuticals Inc. (NGM) on Tuesday reported a loss of $36.4 million in its fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 45 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.

The biotechnology company posted revenue of $18.2 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $6.8 million.

For the year, the company reported that its loss widened to $162.7 million, or $2.03 per share. Revenue was reported as $55.3 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NGM at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up